中级囊症:用囊胺治疗10年的病例报告
Mariko Kawamura1, Daisuke Katagiri2, Yuuka Yamamoto3
1Department of Nephrology, Center Hospital of the National Center for Global Health and Medicine (NCGM), 1-21-1 Toyama Shinjuku-Ku, Tokyo, 162-8655, Japan.
BMC nephrology
|August 27, 2024
概括
中级囊症是一种罕见的疾病,具有独特的诊断挑战. 这一案例突显了用囊胺成功治疗10年的情况,强调了及时诊断和持续管理这种疾病的必要性.
科学领域:
- 罕见的遗传疾病 罕见的遗传疾病
- lysosomal 储存疾病 lysosomal 储存疾病
- 儿科病学 儿科病学
背景情况:
- 囊症是一种罕见的自体逆向性溶酶体储存障碍.
- 中级囊症是一种缓慢进展的亚型,在5%的病例中导致功能衰竭.
- 通常会出现非典型的症状,使诊断复杂化.
研究的目的:
- 报告中级囊病的病例.
- 描述这种罕见疾病的长期管理.
- 强调早期诊断和持续治疗的重要性.
主要方法:
- 在3岁时初步检测出尿路异常后,在12岁时诊断出中级囊症.
- 启动囊胺疗法,并定期监测囊水平.
- 通过两个脏活检评估功能和组织学分析.
主要成果:
- 慢慢进展的功能,尽管持续的蛋白尿.
- 脏活检显示了多核细胞和囊晶体.
- 患者的功能在10年的囊胺治疗中保持稳定.
结论:
- 证明了用囊胺成功治疗中级囊病的10年时间.
- 强调需要准确诊断中级囊病的关键需求.
- 强调需要长期治疗策略来治疗囊病.
相关概念视频
01:24Cystic Fibrosis: Management
148
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
148
01:23Cystic Fibrosis: Pathogenesis
198
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
198
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
01:21Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
01:29Chronic Pancreatitis II: Collaborative Care
78
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
78